Filing Details

Accession Number:
0001628280-25-004461
Form Type:
4
Zero Holdings:
No
Publication Time:
2025-02-07 17:11:19
Reporting Period:
2025-02-05
Filing Date:
2025-02-07
Accepted Time:
2025-02-07 17:11:19
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
1104506 Insmed Inc INSM Pharmaceutical Preparations (2834) 541972729
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1402051 William Lewis 700 Us Highway 202/206
Bridgewater NJ 08807
Chair And Ceo Yes Yes No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Acquisiton 2025-02-05 153,710 $0.00 533,244 No 4 A Direct
Common Stock Disposition 2025-02-06 79,350 $80.90 453,894 No 4 S Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 A Direct
No 4 S Direct
Reported Non-Derivative Holdings
Sec. Name Remaning Holdings Nature of Ownership Explanation
Common Stock 233,924 Indirect By the Katie Procter Dynasty Trust
Common Stock 50,500 Indirect By the William Lewis Family Legacy Trust
Footnotes
  1. Represents shares of common stock acquired upon vesting of Performance Stock Units (PSUs) that were originally granted on January 6, 2022, which vested on February 5, 2025 upon the achievement of the applicable performance and service conditions.
  2. Shares sold to satisfy tax withholding obligations upon the vesting of PSUs and to cover related broker fees.
  3. This is the weighted average sales price representing 79,350 shares sold at prices ranging from $80.57 to $81.43 per share. The reporting person undertakes to provide to the SEC staff, the issuer, or a security holder of the issuer the number of shares sold at each price within the price range upon request.